Skip to main content
. 2023 Oct 5;28(40):2300088. doi: 10.2807/1560-7917.ES.2023.28.40.2300088

Table 1. COVID-19 testing, incidence and epidemic phase in six European countries, weeks 13 to 30 2021.

Average tests per 1,000 population per daya Incidence per 100,000 population per weeka Test positivity rate (%)a Proportion (%) of RT-PCR among all tests Context April–July 2021b
Belgium 4.3 117 3.9 95 Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period.
England 17.4 139 1.1 22 Low incidence before fourth wave in June and July. Non-pharmaceutical interventions reduced during this period.
France 4.9 148 4.3 80 Declining incidence at the end of the third wave until quickly rising cases in July. Non-pharmaceutical interventions reduced during this period.
Italy 3.8 75 2.8 45 Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period.
Romania 1.3 40 4.3 50 Declining incidence at the end of the third wave with stable low rates in July. Non-pharmaceutical interventions remained stable during this period.
Sweden 3.3 125 5.4 90 Declining incidence at the end of the third wave before a slow rise in July. Non-pharmaceutical interventions reduced during this period.

a Average across the period from week 13 to week 30 2021.

b Information on non-pharmaceutical interventions represents the general situation over the study period. More detailed information is provided in the Response Measures Database published by European Centre for Disease Prevention and Control (ECDC) [19].

Source: National data, ECDC, participating country representatives, open online sources.